- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Making better business decisions in the pharma sector
Revolutionizing Pharmaceutical Marketing Effectiveness with Change Management and Technology
Any analysis of future market trends starts from a thorough and accurate understanding of current market conditions, based on the most complete and reliable source of industry data - the reporting companies themselves, in their SEC filings and Annual Reports.
Forecasting the commercial performance of a drug or a pharma company is as much an art as a science, but one widely used measure of future value is the investment analyst consensus forecast, compiled from the reports published by leading financial analysts and brokers.
EvaluatePharma brings together historic sales and detailed company financials with investment analyst consensus sales forecasts in a user-friendly, online service, to deliver unique insight into the past and future performance of the pharmaceuticals and biotechnology sector.
Helping you to make better business decisions
To find out how EvaluatePharma can help you to make better business decisions, visit www.evaluatepharma.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
